Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-01-01

Clinical Trial Update: A Study Comparing Non Myeloablative (Flu-TBI) and Reduced Intensity (FLU-BU-ATG) Conditioning in Allogenic Transplantation [Phase 2]

View source ↗

Summary

Phase 2 study comparing non-myeloablative Flu-TBI conditioning with reduced-intensity Flu-BU-ATG conditioning in allogeneic transplantation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Institut Paoli-Calmettes | Conditions: Allograft, Allogeneic Cell Transplantaion | Phase 2 | Status: COMPLETED